Pharmaceuticals

Follicle-Stimulating Hormone Market Surges With The Rising Adoption Of Assisted Reproductive Technology Is Supporting Development Across The Follicle Stimulating Hormone Market

May 19, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Forecasted Rise In Market Size Of The Follicle Stimulating Hormone Market During The Forecast Period?

The follicle stimulating hormone market has experienced consistent expansion in recent years. This market is projected to grow from $2.12 billion in 2025 to $2.22 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 4.8%. The historic growth can be attributed to progress in recombinant hormone production, an increase in infertility cases, the development of healthcare infrastructure, greater awareness of fertility treatments, and the adoption of urinary FSH formulations.

The follicle stimulating hormone market is expected to show substantial growth in the upcoming years. It is projected to increase to $2.76 billion in 2030, achieving a compound annual growth rate (CAGR) of 5.7%. The expansion during the forecast period is attributed to advancements in FSH delivery systems, the rise of assisted reproductive technology (ART) centers, the broadening reach of telehealth for fertility care, governmental backing for infertility treatments, and a surging demand for personalized medicine in reproductive health. Key trends anticipated in this period include individualized fertility treatments, increased application of recombinant hormones, the incorporation of telemedicine into fertility care, a heightened focus on female reproductive health awareness, and the continued growth of assisted reproductive technology (ART) clinics.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12486&type=smp

Which Major Factors Are Contributing To The Development Of The Follicle Stimulating Hormone Market?

The rising embrace of assisted reproductive technology is anticipated to drive expansion in the follicle-stimulating hormone market in the foreseeable future. Assisted Reproductive Technology (ART) refers to medical interventions designed to assist individuals or couples in achieving conception when conventional methods have been unsuccessful. Within assisted reproductive technology, follicle-stimulating hormone is a recognized treatment employed to enhance the likelihood of a successful pregnancy for individuals or couples facing fertility challenges. For example, data from March 2024, provided by the US department of Health and Human services, a US-based government entity, indicates that the application of assisted reproductive technology (ART) correlates with increasing maternal age. In 2023, ART was utilized in 9% of live births among women aged 40-45, escalating to almost one-third for those women who were 45 and older. Furthermore, the prevalence of ART use exhibits regional differences across the U.S. Consequently, the growing acceptance of assisted reproductive technology is acting as a primary driver for the follicle-stimulating hormone market.

How Is The Follicle Stimulating Hormone Market Examined Through Segment Analysis?

The follicle stimulating hormone market covered in this report is segmented –

1) By Type: Recombinant FSH, Urinary FSH

2) By Application: Infertility Treatment, Assisted Reproductive Technology (ART), Other Applications

3) By End-Users: Infertility Center, Hospitals, Other End-Users

Subsegments:

1) By Recombinant FSH: Pure Recombinant FSH, Mixed Recombinant FSH Formulations

2) By Urinary FSH: Purified Urinary FSH, Urinary FSH Combined With Other Hormones

Which Trends Are Shaping The Follicle Stimulating Hormone Market Landscape?

Leading companies within the follicle-stimulating hormone market are developing innovative products, such as multi-hormone at-home diagnostic testing systems, to deliver more accurate, continuous, and patient-focused insights into hormone health and reproductive function. These multi-hormone at-home diagnostic testing systems are integrated, user-friendly platforms designed to measure FSH alongside other key reproductive hormones through non-invasive sampling, enabling real-time monitoring, personalized health assessments, and improved clinical decision-making without requiring in-clinic testing. For instance, in July 2024, Proov, a US-based women’s health company, launched the Proov Empower Perimenopause Testing System. Proov Empower offers comprehensive and personalized insights into how a woman’s changing hormones affect her overall health and wellness. This non-invasive, multi-time point urine test measures four key hormones FSH, estrogen marker E1G, progesterone marker PdG, and LH that influence symptoms and the perimenopause experience. By providing periodic retesting, Proov Empower helps women track hormone fluctuations and symptoms, serving as a valuable guide during the transition to menopause.

Who Are The Major Companies Operating In The Follicle Stimulating Hormone Market?

Major companies operating in the follicle stimulating hormone market are Pfizer Inc., Sanofi S.A., Merck KGaA, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd., Cipla Ltd., Ferring Pharmaceuticals Inc., Lupin Limited, Zydus Lifesciences Limited, Emcure Pharmaceuticals Ltd., IBSA Group, Taj Pharmaceuticals Ltd., Trumac Healthcare, Midas Pharma GmbH, Shanghai Techwell Biopharmaceutical Co. Ltd., Livzon Pharmaceutical Group Inc., Anhui Anke Biotechnology Group Co. Ltd., LG Chem Life Sciences, Genpharm Inc., Biogenix Inc. Pvt. Ltd.

Access The Complete Follicle Stimulating Hormone Market Report:

https://www.thebusinessresearchcompany.com/report/follicle-stimulating-hormone-global-market-report

Which Region Commands The Largest Share Of The Follicle Stimulating Hormone Market?

North America was the largest region in the follicle stimulating hormone market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the follicle stimulating hormone market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Follicle Stimulating Hormone Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=12486&type=smp

Browse Through More Reports Similar to the Global Follicle Stimulating Hormone Market 2026, By The Business Research Company

Follicle Stimulating Hormone Market Report 2026

https://www.thebusinessresearchcompany.com/report/follicle-stimulating-hormone-global-market-report

Hormone Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/hormone-therapy-global-market-report

Human Growth Hormone Market Report 2026

https://www.thebusinessresearchcompany.com/report/human-growth-hormone-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795